+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hydrocortisone Global Market Report 2024

  • PDF Icon

    Report

  • 175 Pages
  • August 2024
  • Region: Global
  • The Business Research Company
  • ID: 5991028
Hydrocortisone is a corticosteroid hormone naturally produced by the adrenal glands, essential for regulating metabolism and immune responses. It is synthesized and utilized in treating various conditions, primarily serving as an anti-inflammatory agent, commonly applied topically to alleviate skin inflammation and itching.

The principal forms of hydrocortisone include creams, injections, and tablets. Hydrocortisone cream is a topical medication applied directly to the skin to reduce inflammation, itching, and irritation caused by conditions such as eczema, dermatitis, and insect bites. These products are administered via different routes including parenteral, oral, and topical methods, addressing conditions such as adrenocortical dysfunction, adrenergic syndrome, hypercalcemia, thyroiditis, rheumatoid arthritis, dermatitis, asthma, chronic obstructive pulmonary disease (COPD), among others. Distribution channels for hydrocortisone products encompass hospital pharmacies, retail pharmacies, and online platforms.

The hydrocortisone market research report is one of a series of new reports that provides hydrocortisone market statistics, including hydrocortisone industry global market size, regional shares, competitors with an hydrocortisone market share, detailed hydrocortisone market segments, market trends and opportunities, and any further data you may need to thrive in the hydrocortisone industry. This hydrocortisone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hydrocortisone market size has grown strongly in recent years It will grow from $1.43 billion in 2023 to $1.52 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth observed in the historic period can be attributed to several factors, including the increasing prevalence of skin disorders, an aging population, heightened awareness and improved accessibility to treatments, growth within the pharmaceutical industry, and expansion into emerging markets.

The hydrocortisone market size is expected to see strong growth in the next few years It will grow to $1.96 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth in the forecast period can be attributed to advancements in technology, a surge in demand for over-the-counter (OTC) products, increased investments in research and development, rising disposable incomes, and expanded distribution channels. Key trends expected in the forecast period include a focus on natural ingredients, the development of combination therapies, personalized treatment options, the introduction of hydrocortisone-infused products, and a growing emphasis on sustainability.

The hydrocortisone market is expected to grow due to the increasing prevalence of inflammatory and autoimmune diseases. These conditions involve the immune system attacking the body's tissues, leading to chronic inflammation and tissue damage. The rising adoption of treatments for these diseases is driven by their growing prevalence and advancements in medical therapies. Hydrocortisone is utilized in severe asthma exacerbations and other inflammatory and autoimmune diseases to reduce inflammation and improve respiratory function quickly, often administered intravenously in emergency situations. For example, in May 2024, data from the National Center for Health Statistics indicated a rise in asthma prevalence among adults in the United States from 8.4% in 2021 to 8.7% in 2022, with an increase in asthma episodes from 3.3% to 3.7% over the same period.

Leading companies in the hydrocortisone market are focusing on developing combination therapies, such as lotions containing butyrate active ingredients, to enhance treatment effectiveness and expand their product offerings. Hydrocortisone combined with butyrate lotion aims to synergize anti-inflammatory properties with butyrate's immunomodulatory effects, potentially improving skin barrier function in managing skin conditions. For instance, in November 2023, J. Molner AS., an Estonian pharmaceutical firm, launched Hydrocortisone Butyrate Lotion, 0.1%, in the United States, marking a significant step in its strategy to expand globally. This product addresses inflammatory skin conditions, underscoring Molner's commitment to broadening its international market presence.

In March 2022, Advent International Corporation, a US-based private equity firm, acquired Perrigo Company plc's pharmaceutical businesses in Mexico and Brazil, aiming to bolster its regional investment strategy in the pharmaceutical sector. This acquisition strengthens Advent's position in the market, leveraging its extensive industry experience spanning more than two decades. Perrigo Company plc, based in Ireland, specializes in over-the-counter health and wellness solutions, including hydrocortisone creams.

Major companies operating in the hydrocortisone market are Pfizer Inc., Johnson & Johnson, Merck & Co Inc, AbbVie Inc., Bayer AG, Novartis AG, The Dow Chemical Company, GlaxoSmithKline plc (GSK), Viatris Inc., Solvay SA, Teva Pharmaceutical Industries Ltd., Alcon Inc, Sandoz International GmbH, Valeant Pharmaceuticals International Inc, Fresenius Kabi AG, Macleods Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Bausch & Lomb Incorporated, Hikma Pharmaceuticals PLC, Aspen Pharmacare Holdings Limited, Ivax Pharmaceuticals Inc, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Limited, Impax Laboratories LLC, Akorn Incorporated, Taro Pharmaceutical Industries Ltd, Lannett Company Inc, Salix Pharmaceuticals Inc.

North America was the largest region in the hydrocortisone market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hydrocortisone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hydrocortisone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hydrocortisone market consists of sales of hydrocortisone creams, ointments, lotions, and oral formulations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Hydrocortisone Market Characteristics3. Hydrocortisone Market Trends And Strategies
4. Hydrocortisone Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Hydrocortisone Market Size and Growth
5.1. Global Hydrocortisone Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Hydrocortisone Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Hydrocortisone Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Hydrocortisone Market Segmentation
6.1. Global Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cream
  • Injection
  • Tablet
6.2. Global Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Parenteral
  • Oral
  • Topical
6.3. Global Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Adrenocortical Dysfunction
  • Adrenergic Syndrome
  • High Blood Calcium
  • Thyroiditis
  • Rheumatoid Arthritis
  • Dermatitis
  • Asthma And Chronic Obstructive Pulmonary Disease
  • Other Applications
6.4. Global Hydrocortisone Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
7. Hydrocortisone Market Regional And Country Analysis
7.1. Global Hydrocortisone Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Hydrocortisone Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Hydrocortisone Market
8.1. Asia-Pacific Hydrocortisone Market Overview
(Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies)
8.2. Asia-Pacific Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Hydrocortisone Market
9.1. China Hydrocortisone Market Overview
9.2. China Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Hydrocortisone Market
10.1. India Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Hydrocortisone Market
11.1. Japan Hydrocortisone Market Overview
11.2. Japan Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Hydrocortisone Market
12.1. Australia Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Hydrocortisone Market
13.1. Indonesia Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Hydrocortisone Market
14.1. South Korea Hydrocortisone Market Overview
14.2. South Korea Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Hydrocortisone Market
15.1. Western Europe Hydrocortisone Market Overview
15.2. Western Europe Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Hydrocortisone Market
16.1. UK Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Hydrocortisone Market
17.1. Germany Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Hydrocortisone Market
18.1. France Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Hydrocortisone Market
19.1. Italy Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Hydrocortisone Market
20.1. Spain Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Hydrocortisone Market
21.1. Eastern Europe Hydrocortisone Market Overview
21.2. Eastern Europe Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Hydrocortisone Market
22.1. Russia Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Hydrocortisone Market
23.1. North America Hydrocortisone Market Overview
23.2. North America Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Hydrocortisone Market
24.1. USA Hydrocortisone Market Overview
24.2. USA Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Hydrocortisone Market
25.1. Canada Hydrocortisone Market Overview
25.2. Canada Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Hydrocortisone Market
26.1. South America Hydrocortisone Market Overview
26.2. South America Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Hydrocortisone Market
27.1. Brazil Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Hydrocortisone Market
28.1. Middle East Hydrocortisone Market Overview
28.2. Middle East Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Hydrocortisone Market
29.1. Africa Hydrocortisone Market Overview
29.2. Africa Hydrocortisone Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Hydrocortisone Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Hydrocortisone Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Hydrocortisone Market Competitive Landscape And Company Profiles
30.1. Hydrocortisone Market Competitive Landscape
30.2. Hydrocortisone Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Johnson & Johnson
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Merck & Co Inc
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. AbbVie Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Bayer AG
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Hydrocortisone Market Other Major And Innovative Companies
31.1. Novartis AG
31.2. The Dow Chemical Company
31.3. GlaxoSmithKline plc (GSK)
31.4. Viatris Inc.
31.5. Solvay SA
31.6. Teva Pharmaceutical Industries Ltd.
31.7. Alcon Inc
31.8. Sandoz International GmbH
31.9. Valeant Pharmaceuticals International Inc
31.10. Fresenius Kabi AG
31.11. Macleods Pharmaceuticals Limited
31.12. Sun Pharmaceutical Industries Ltd.
31.13. Bausch & Lomb Incorporated
31.14. Hikma Pharmaceuticals PLC
31.15. Aspen Pharmacare Holdings Limited
32. Global Hydrocortisone Market Competitive Benchmarking33. Global Hydrocortisone Market Competitive Dashboard34. Key Mergers And Acquisitions In The Hydrocortisone Market
35. Hydrocortisone Market Future Outlook and Potential Analysis
35.1 Hydrocortisone Market In 2028 - Countries Offering Most New Opportunities
35.2 Hydrocortisone Market In 2028 - Segments Offering Most New Opportunities
35.3 Hydrocortisone Market In 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright And Disclaimer

Executive Summary

Hydrocortisone Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hydrocortisone market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for hydrocortisone ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hydrocortisone market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: Cream; Injection; Tablet
2) By Route Of Administration: Parenteral; Oral; Topical
3) By Application: Adrenocortical Dysfunction; Adrenergic Syndrome; High Blood Calcium; Thyroiditis; Rheumatoid Arthritis; Dermatitis; Asthma And Chronic Obstructive Pulmonary Disease; Other Application
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Key Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co Inc; AbbVie Inc.; Bayer AG

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

  • Pfizer Inc.
  • Johnson & Johnson
  • Merck & Co Inc
  • AbbVie Inc.
  • Bayer AG
  • Novartis AG
  • The Dow Chemical Company
  • GlaxoSmithKline plc (GSK)
  • Viatris Inc.
  • Solvay SA
  • Teva Pharmaceutical Industries Ltd.
  • Alcon Inc
  • Sandoz International GmbH
  • Valeant Pharmaceuticals International Inc
  • Fresenius Kabi AG
  • Macleods Pharmaceuticals Limited
  • Sun Pharmaceutical Industries Ltd.
  • Bausch & Lomb Incorporated
  • Hikma Pharmaceuticals PLC
  • Aspen Pharmacare Holdings Limited
  • Ivax Pharmaceuticals Inc
  • Glenmark Pharmaceuticals Ltd.
  • Torrent Pharmaceuticals Limited
  • Impax Laboratories LLC
  • Akorn Incorporated
  • Taro Pharmaceutical Industries Ltd
  • Lannett Company Inc
  • Salix Pharmaceuticals Inc